MMVYX
Price
$10.00
Change
-$0.14 (-1.38%)
Updated
Dec 17 closing price
VSIAX
Price
$88.58
Change
-$1.09 (-1.22%)
Updated
Dec 17 closing price
Ad is loading...

MMVYX vs VSIAX

Header iconMMVYX vs VSIAX Comparison
Open Charts MMVYX vs VSIAXBanner chart's image
MassMutual Small Company Val Svc
Price$10.00
Change-$0.14 (-1.38%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$88.58
Change-$1.09 (-1.22%)
VolumeN/A
CapitalizationN/A
MMVYX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MMVYX vs. VSIAX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MMVYX is a Sell and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. MMVYX (129M). VSIAX pays higher dividends than MMVYX: VSIAX (2.01) vs MMVYX (0.60). MMVYX was incepted earlier than VSIAX: MMVYX (23 years) vs VSIAX (13 years). MMVYX is a more actively managed with annual turnover of: 44.00 vs. VSIAX (16.00). MMVYX has a lower initial minimum investment than VSIAX: MMVYX (0) vs VSIAX (3000). MMVYX annual gain was more profitable for investors over the last year : 17.47 vs. VSIAX (16.23). VSIAX return over 5 years is better than : 52.83 vs. MMVYX (10.29).
MMVYXVSIAXMMVYX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years13 years-
Gain YTD15.23015.031101%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets129M63B0%
Annual Yield % from dividends0.602.0130%
Returns for 1 year17.4716.23108%
Returns for 3 years-6.9320.67-34%
Returns for 5 years10.2952.8319%
Returns for 10 years-24.83105.65-24%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics